Church & Dwight (NYSE:CHD) Price Target Raised to $97.00

Church & Dwight (NYSE:CHD) had its target price lifted by Barclays from $93.00 to $97.00 in a research report sent to investors on Thursday,Benzinga reports. Barclays currently has an underweight rating on the stock.

Several other equities research analysts also recently weighed in on the stock. Piper Sandler reduced their price objective on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $105.00 price target on shares of Church & Dwight in a research note on Monday, February 3rd. JPMorgan Chase & Co. lowered their price objective on shares of Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Truist Financial upped their target price on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, February 3rd. Finally, Stifel Nicolaus lifted their price target on Church & Dwight from $103.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Church & Dwight presently has an average rating of “Hold” and a consensus price target of $111.81.

Church & Dwight Stock Up 0.7 %

Church & Dwight stock opened at $109.14 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. Church & Dwight has a one year low of $96.35 and a one year high of $116.46. The company has a 50-day simple moving average of $107.65 and a 200-day simple moving average of $105.93. The firm has a market capitalization of $26.86 billion, a P/E ratio of 46.05, a P/E/G ratio of 3.32 and a beta of 0.57.

Church & Dwight (NYSE:CHD) last posted its earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the business posted $0.65 earnings per share. As a group, equities analysts expect that Church & Dwight will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were given a $0.295 dividend. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a dividend yield of 1.08%. The ex-dividend date was Friday, February 14th. Church & Dwight’s dividend payout ratio (DPR) is 49.79%.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of Church & Dwight stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the transaction, the executive vice president now owns 10,497 shares of the company’s stock, valued at $1,217,442.06. The trade was a 83.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Rene Hemsey sold 11,060 shares of the stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total transaction of $1,216,378.80. Following the completion of the sale, the executive vice president now directly owns 6,437 shares of the company’s stock, valued at $707,941.26. This trade represents a 63.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 65,570 shares of company stock worth $7,538,449. 2.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Church & Dwight

Several institutional investors and hedge funds have recently modified their holdings of CHD. Cerity Partners LLC boosted its position in Church & Dwight by 51.5% during the third quarter. Cerity Partners LLC now owns 52,259 shares of the company’s stock valued at $5,473,000 after purchasing an additional 17,774 shares during the last quarter. Kingsview Wealth Management LLC lifted its holdings in shares of Church & Dwight by 3.3% during the 3rd quarter. Kingsview Wealth Management LLC now owns 3,373 shares of the company’s stock valued at $353,000 after buying an additional 107 shares during the last quarter. Larson Financial Group LLC grew its stake in shares of Church & Dwight by 149.3% in the 3rd quarter. Larson Financial Group LLC now owns 2,730 shares of the company’s stock valued at $286,000 after buying an additional 1,635 shares in the last quarter. Daiwa Securities Group Inc. increased its holdings in Church & Dwight by 11.8% in the third quarter. Daiwa Securities Group Inc. now owns 29,939 shares of the company’s stock worth $3,135,000 after buying an additional 3,160 shares during the last quarter. Finally, Fisher Asset Management LLC raised its position in Church & Dwight by 10.0% during the third quarter. Fisher Asset Management LLC now owns 31,256 shares of the company’s stock valued at $3,273,000 after acquiring an additional 2,834 shares in the last quarter. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.